Skip to content
healthcare.dev

2% LIDOCAINE HCI

NDC 51662-1467, 2% LIDOCAINE HCI, injection, solution, from HF Acquisition Co LLC, DBA HealthFirst.

Product NDC
51662-1467
Status
Listed
Labeler
HF Acquisition Co LLC, DBA HealthFirst
Dosage form
INJECTION, SOLUTION
Route
INFILTRATION, PERINEURAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA088327
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1467 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIDOCAINE HYDROCHLORIDE20 mg/mL

Pharmacologic classes

Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]

Package NDCNDC-11Package
51662-1467-15166214670120 mL in 1 VIAL, MULTI-DOSE (51662-1467-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/999b1c7b-3495-926a-e053-2a95a90ab206

Use it

Look up 51662-1467 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1467 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51662-1467. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.